OA Online reports that Deep Lens Inc., “a digital pathology startup combining artificial intelligence (AI) and advanced, cloud-based, pathology workflows to improve efficiency and enable patient access to cancer trials” emerged from stealth mode with $3.2 million.
Who is Deep Lens? They purport to be one of the world’s first digital pathology cloud platforms that for over ten years has allowed pathology groups to collaborate on groundbreaking cancer research across dozens of cancer types. Based on considerable feedback, they have been enhancing their system to include AI-powered image detection and workflow support, telepathology, collaboration, cloud storage and build in API’s for integration. A search on LinkedIn evidences only a few employees, however, the founders appear experienced and well-connected in industry— a clear prerequisite for start-up success.Source: OA Online